Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.

Zhou, J; Luo, J; Wu, K; Yun, E-J; Kapur, P; Pong, R-C; Du, Y; Wang, B; Authement, C; Hernandez, E; Yang, J; Xiao, G; Cha, T-L; Wu, H-C; Wu, D; Margulis, V; Lotan, Y; Brugarolas, J; He, D; Hsieh, J-T

Zhou, J; Luo, J; Wu, K; Yun, E-J; Kapur, P; Pong, R-C; Du, Y; Wang, B; Authement, C; Hernandez, E; Yang, J; Xiao, G; Cha, T-L; Wu, H-C; Wu, D; Margulis, V; Lotan, Y; Brugarolas, J; He, D; Hsieh, J-T.

Affiliation

Zhou J; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
Luo J; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Wu K; Department of Urology, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yun EJ; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
Kapur P; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pong RC; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Du Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Wang B; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
Authement C; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
Hernandez E; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Yang J; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Xiao G; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Cha TL; Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Wu HC; Division of Urology, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China, Taiwan.
Wu D; Department of Urology, China Medical University Hospital, Taichung, Republic of China, Taiwan.
Margulis V; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.
Lotan Y; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Brugarolas J; Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
He D; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Hsieh JT; Department of Urology, First Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China.

Oncogene ; 35(35): 4663-74, 2016 09 01.

Article de En | MEDLINE | ID: mdl-26876207

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Résistance aux médicaments antinéoplasiques / Protéines d'activation de la ras GTPase / Prolifération cellulaire / Sérine-thréonine kinases TOR Type d'étude: Prognostic_studies Limites: Adult / Aged / Animals / Female / Humans / Male / Middle aged Langue: En Journal: Oncogene Sujet du journal: BIOLOGIA MOLECULAR / NEOPLASIAS Année: 2016 Type de document: Article Pays d'affiliation: Chine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google